Chickasaw Nation Industries, Inc. is fulfilling its role in stemming the coronavirus outbreak by continuing its work for the Centers for Disease Control and Prevention (CDC). CNI recently acknowledged its employees for both serving on the front lines, in the wake of the COVID-19 pandemic, and for providing technical assistance, consultation and operational management support to the agency.
Chickasaw Nation Industries, Inc. (CNI) performs projects for the CDC National Center for Immunization and Respiratory (NCIRD), Influenza Division.
“Our services help maintain services critical to the mission of [the CDC’s Influenza Division] to provide laboratory and epidemiology surveillance and technical assistance to state, national and international health entities and ministries throughout the world,” CNI recently stated on LinkedIn.
CNI has a long history of working with the U.S. Department of Health and Human Services to enhance and protect the health and wellbeing of all Americans. Among CNI’s many focuses has been: assisting local health departments combat the Zika crisis, and supporting over 50 CDC offices worldwide with technology.
CNI’s health services include:
- Public Health Threat Response
- BSL 3+ Laboratory Technical Support
- Epidemiology & Data Management
- Health and Medical Staff Augmentation
- Payment Error & Evaluation
- Medical Claims & Record Review
To offer an overview of CNI’s evolution and broad impact: In less than 20 years, CNI has gone from a fledgling business awaiting 8(a) status approval to a giant conglomerate with 24 subsidiaries and employing 1,850 people.
CNI specializes in government contracting, manufacturing and fluid filtration for clients that include the U.S. military, government agencies, the Ford Motor Company, and heavyweights of the energy industry.
Recently, the CNI team, in partnership with the FDA, was awarded a FedHealthIT Innovation Award.